| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.436 | 0 | 0 | 0 | 0 | 22.741 | 84.044 | 44.424 | 18.120 | 0 |
| Total Income - EUR | 6.436 | 0 | 0 | 2.149 | 0 | 22.741 | 84.620 | 44.889 | 18.629 | 0 |
| Total Expenses - EUR | 584 | 53 | 16 | 4.644 | 0 | 39 | 11.708 | 846 | 1.513 | 290 |
| Gross Profit/Loss - EUR | 5.852 | -53 | -16 | -2.495 | 0 | 22.702 | 72.913 | 44.043 | 17.116 | -290 |
| Net Profit/Loss - EUR | 5.659 | -53 | -16 | -2.559 | 0 | 22.088 | 70.390 | 42.723 | 14.394 | -290 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Serlucrin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.612 | 4.565 | 4.488 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.531 | 6.411 | 6.286 | 8.017 | 7.862 | 29.801 | 82.028 | 58.554 | 30.102 | 7.210 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 707 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 74.957 | 32.051 | 16.376 | 29 |
| Cash | 6.531 | 6.411 | 6.286 | 8.017 | 7.862 | 29.801 | 7.071 | 25.796 | 13.726 | 7.182 |
| Shareholders Funds | 11.143 | 10.976 | 10.774 | 8.017 | 7.862 | 29.801 | 55.695 | 50.288 | 21.937 | 7.210 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 0 | 0 | 0 | 0 | 0 | 26.332 | 8.266 | 8.165 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4611 - 4611" | |||||||||
| CAEN Financial Year |
4611
|
|||||||||
Comments - Serlucrin Srl